Mirae Asset Global Investments Co., Ltd. Hutchmed (China) LTD Transaction History
Mirae Asset Global Investments Co., Ltd.
- $30.9 Billion
- Q3 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,199 shares of HCM stock, worth $18,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,199
Previous 1,198
0.08%
Holding current value
$18,080
Previous $18,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding HCM
# of Institutions
57Shares Held
5.74MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.47MShares$37.2 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M909KShares$13.7 Million0.02% of portfolio
-
Jane Street Group, LLC New York, NY340KShares$5.13 Million0.0% of portfolio
-
State Street Corp Boston, MA318KShares$4.79 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.76 Million0.1% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.61B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...